Health Hope Pharma Signs Vaccine License Agreement with Gilead Sciences Health Hope Pharma has signed an exclusive licensing agreement with Gilead Sciences to develop oral drug formulations, particularly targeting oncology treatments.

Health Hope Pharma Signs Vaccine License Agreement with Gilead Sciences #Hong_Kong #Gilead_Sciences #Encequidar #Health_Hope_Pharma

Health Hope Pharma and Gilead Sciences Announce Landmark Licensing Deal for Encequidar Health Hope Pharma has entered an exclusive global licensing agreement with Gilead Sciences for encequidar, a pioneering P-glycoprotein inhibitor, aiming to revolutionize oral drug formulations.

Health Hope Pharma and Gilead Sciences Announce Landmark Licensing Deal for Encequidar #Hong_Kong #Hong_Kong_SAR #Gilead_Sciences #Encequidar #Health_Hope_Pharma

Hanmi Pharm Partners with Gilead for Innovative Oral Delivery Platform Hanmi Pharmaceuticals has entered a licensing agreement with Gilead Sciences, focusing on developing the oral drug Encequidar, showcasing advancements in drug delivery technology.

Hanmi Pharm Partners with Gilead for Innovative Oral Delivery Platform #South_Korea #Seoul #Gilead_Sciences #Hanmi_Pharm #Encequidar